Clinical Trials Browser

INDUSTRY × Has results × Surgical Procedures, Operative × Clear all

NCT04024462 2026-02-20

A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer

Phase 3 Completed

200 enrolled 16 charts

HER2-positive Early Breast Cancer

NCT05415215 2026-02-10

ProHer

Phase 3 Completed

346 enrolled 20 charts

Breast Neoplasms, Patient Preference, Inflammatory Breast Neoplasms

NCT04770272 2026-01-12

neoMono

Phase 2 Terminated

442 enrolled 42 charts

Triple Negative Breast Neoplasms

NCT04109066 2025-01-08

CheckMate 7FL

Phase 3 Completed

521 enrolled 17 charts

Breast Neoplasms, Neoplasms

NCT03493854 2024-06-26

FeDeriCa

Phase 3 Completed

500 enrolled 28 charts 1 FDA

Breast Neoplasms

NCT03165994 2024-05-02

APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers

Phase 2 Completed

34 enrolled 18 charts

Gastrointestinal

Esophageal Neoplasms

NCT02586025 2023-05-22

PEONY

Phase 3 Completed

329 enrolled 33 charts

Breast Neoplasms

NCT03916744 2023-03-10

A Study of Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer

Phase 1 Completed

75 enrolled 24 charts

Breast Neoplasms

NCT04436744 2023-02-02

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)

Phase 2 Completed

221 enrolled 21 charts

Breast Neoplasms

NCT01265849 2022-08-19

IT-MATTERS

Phase 3 Completed

928 enrolled 25 charts

Squamous Cell Carcinoma of Head and Neck

NCT00840749 2020-07-14

STARS

Phase NA Terminated

36 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT02301143 2019-03-20

LAPACT

Phase 2 Completed

107 enrolled 18 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00865189 2017-08-04

INOVA

Phase 2 Completed

91 enrolled 16 charts

Gastrointestinal

Rectal Neoplasms

NCT00704808 2015-09-09

Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)

180 enrolled 6 charts

Glioblastoma

NCT00849472 2014-03-04

Treatment With Pazopanib for Neoadjuvant Breast Cancer

Phase 2 Completed

101 enrolled 16 charts

Breast Neoplasms

NCT00191308 2011-10-21

Molecular Profiling in Lung Cancer Patients

Phase 2 Completed

30 enrolled 11 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT00515086 2011-09-22

Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)

Phase 2 Terminated

41 enrolled 11 charts

Dyschromatosis symmetrica hereditaria 1, Glioblastoma

NCT00191789 2010-07-27

Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer

Phase 2 Completed

65 enrolled 13 charts

Breast Neoplasms